Analyst Larry Biegelsen from Wells Fargo maintained a Buy rating on Abbott Laboratories (ABT – Research Report) and keeping the price ...
If a company's history and track record were good enough reasons to buy its shares, it'd be easy to make a case for investing ...
Increasing diabetes care awareness, wider insurance coverage and preference for devices that do not need finger pricks have ...